Matches in Nanopublications for { ?s ?p "[We examined the associations of CTLA4 single-nucleotide polymorphisms (SNPs) at promoter site -318 and exon-1 site 49 with clearance of hepatitis C virus (HCV) after treatment with combination interferon-alpha plus ribavirin (IFN-alpha+R) therapy in 79 white sustained responders (SRs) and 79 nonresponders (NRs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP633709.RAZ2iieYmgwZYpIAzMLMVmKspcSYuRFqWKC8wI425Unh0130_assertion description "[We examined the associations of CTLA4 single-nucleotide polymorphisms (SNPs) at promoter site -318 and exon-1 site 49 with clearance of hepatitis C virus (HCV) after treatment with combination interferon-alpha plus ribavirin (IFN-alpha+R) therapy in 79 white sustained responders (SRs) and 79 nonresponders (NRs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633709.RAZ2iieYmgwZYpIAzMLMVmKspcSYuRFqWKC8wI425Unh0130_provenance.
- NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_assertion description "[We examined the associations of CTLA4 single-nucleotide polymorphisms (SNPs) at promoter site -318 and exon-1 site 49 with clearance of hepatitis C virus (HCV) after treatment with combination interferon-alpha plus ribavirin (IFN-alpha+R) therapy in 79 white sustained responders (SRs) and 79 nonresponders (NRs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_provenance.
- assertion description "[We examined the associations of CTLA4 single-nucleotide polymorphisms (SNPs) at promoter site -318 and exon-1 site 49 with clearance of hepatitis C virus (HCV) after treatment with combination interferon-alpha plus ribavirin (IFN-alpha+R) therapy in 79 white sustained responders (SRs) and 79 nonresponders (NRs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP56110.RA0lWkUJxgZXGuksL8JjYgDO5UDw3olh4r_zU05A8WZ9Q130_assertion description "[We examined the associations of CTLA4 single-nucleotide polymorphisms (SNPs) at promoter site -318 and exon-1 site 49 with clearance of hepatitis C virus (HCV) after treatment with combination interferon-alpha plus ribavirin (IFN-alpha+R) therapy in 79 white sustained responders (SRs) and 79 nonresponders (NRs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP56110.RA0lWkUJxgZXGuksL8JjYgDO5UDw3olh4r_zU05A8WZ9Q130_provenance.
- NP79250.RArfD23E09olZAqJTl1xFI91idA5cmAUQpBA9KN_ozGLw130_assertion description "[We examined the associations of CTLA4 single-nucleotide polymorphisms (SNPs) at promoter site -318 and exon-1 site 49 with clearance of hepatitis C virus (HCV) after treatment with combination interferon-alpha plus ribavirin (IFN-alpha+R) therapy in 79 white sustained responders (SRs) and 79 nonresponders (NRs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79250.RArfD23E09olZAqJTl1xFI91idA5cmAUQpBA9KN_ozGLw130_provenance.